61 related articles for article (PubMed ID: 1928037)
1. The chemotactic response of human granulocytes to Clostridium difficile toxin A is age dependent.
Triadafilopoulos G; Shah MH; Pothoulakis C
Am J Gastroenterol; 1991 Oct; 86(10):1461-5. PubMed ID: 1928037
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.
Pothoulakis C; Sullivan R; Melnick DA; Triadafilopoulos G; Gadenne AS; Meshulam T; LaMont JT
J Clin Invest; 1988 Jun; 81(6):1741-5. PubMed ID: 2838520
[TBL] [Abstract][Full Text] [Related]
3. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes.
Jefferson KK; Smith MF; Bobak DA
J Immunol; 1999 Nov; 163(10):5183-91. PubMed ID: 10553038
[TBL] [Abstract][Full Text] [Related]
4. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
7. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment.
Mitty RD; LaMont JT
Gastroenterologist; 1994 Mar; 2(1):61-9. PubMed ID: 8055233
[TBL] [Abstract][Full Text] [Related]
9. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.
Castagliuolo I; Keates AC; Wang CC; Pasha A; Valenick L; Kelly CP; Nikulasson ST; LaMont JT; Pothoulakis C
J Immunol; 1998 Jun; 160(12):6039-45. PubMed ID: 9637520
[TBL] [Abstract][Full Text] [Related]
11. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
12. [Six years evaluation of Clostridium difficile associated diarrhea].
Ercis S; Ergin A; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
[TBL] [Abstract][Full Text] [Related]
13. Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model.
Alcantara C; Stenson WF; Steiner TS; Guerrant RL
J Infect Dis; 2001 Sep; 184(5):648-52. PubMed ID: 11474431
[TBL] [Abstract][Full Text] [Related]
14. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
[TBL] [Abstract][Full Text] [Related]
15. Clostridium difficile and antibiotic associated diarrhoea in Sweden.
Aronsson B; Möllby R; Nord CE
Scand J Infect Dis Suppl; 1982; 35():53-8. PubMed ID: 6962998
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated diarrhea in the elderly.
Brandt LJ; Kosche KA; Greenwald DA; Berkman D
Am J Gastroenterol; 1999 Nov; 94(11):3263-6. PubMed ID: 10566727
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxin and enterotoxin production by Clostridium difficile.
Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
[TBL] [Abstract][Full Text] [Related]
18. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice.
Mykoniatis A; Anton PM; Wlk M; Wang CC; Ungsunan L; Blüher S; Venihaki M; Simeonidis S; Zacks J; Zhao D; Sougioultzis S; Karalis K; Mantzoros C; Pothoulakis C
Gastroenterology; 2003 Mar; 124(3):683-91. PubMed ID: 12612907
[TBL] [Abstract][Full Text] [Related]
19. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
